Take local practice into account
Chinese patent practice is very different from that of the EU, US, or Japan. Amy Feng of Liu, Shen & Associates urges firms to consider it when patenting second medical indications In China
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: